Michael Weickert

San Francisco, California, US

♦ Strategic & Entrepreneurial Executive ♦ Trail-blazing leadership in biotech, medical device & pharmaceutical business
Michael's Skills
Business Development
Fundraising
Marketing
Product Management
Background

About Michael

Commercial strategy architect and company leader:
• Personally initiated and negotiated Seed through Series C investment rounds and partnerships worth more than $175 Million.
• Grew SEA Medical from inception to 26 employees and $5M in annual revenue.
• For SEA Medical, raised seed through Series B funding and signed two strategic deals.
• In less than one month, prepared business plan for start-up founded by Nobel Prize winning scientist.
• Developed product strategy and selected products for four Medical Device and Biotechnology Drug Delivery companies.
• Created new businesses – initiated Anti-infectives Business Unit at Nektar with four products in development - several were part of 2008 $115M Novartis transaction.

Successful product development leader:
• Led Product Development and Project Management functions at two start-ups.
• Led flagship proprietary products in development at Nektar, directing clinical, regulatory and CMC activities and leading all regulatory interactions with FDA and EMEA.
• Led development teams at 4 different companies for products from preclinical stage through NDA.
• Managed product development partnerships at Nektar with Biogen and Enzon.

Business and scientific communicator:
• “Best Presenter" out of 81 companies participating in the 13th annual New York Venture Summit, 2013
• Presented Nektar’s first proprietary product to analysts and investors, NYC, 2005.
• One month after forming company, prepared and presented business plan at an international competition winning best Biotech company and First Runner-up overall.
• 22 peer-reviewed scientific publications authored or co-authored.
• 31 presentations at national and international meetings on Program Management, Finance and R&D
• Co-Chaired 2001 Project Management and Finance DIA Workshop, Ft. Lauderdale, FL. Presented the highest rated peer presentation at the 2000 Project Management and Finance DIA Workshop.
• Wrote, co-wrote or edited numerous regulatory documents including US and EU orphan drug applications (both granted), waivers (granted), Fast Track application (granted), pre-meeting packages.

Work Experience

President at Wit Creek Partners

Wit Creek Partners

March 2007 - December 2016